Sort
39,280 grants matching “leukemia”
Tumor Microenvironment in Cancer Progression
$661,011Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma
$660,954Robert Taylor Ripley · Baylor College Of Medicine · R37 · FY2024 · CA
Studies of Atomic Bomb Survivors
$660,698Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Inflammation, Macrophage Differentiation, and Cancer
$660,538Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Clinical Cancer Cytogenetics
$660,429Diane C Arthur · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
$660,371Craig A Elmets · University Of Alabama At Birmingham · P01 · FY2017 · CA
Project 1: Chromosome Inheritance
$660,178Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2018 · CA
FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS
$660,136Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2013 · HL
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu
$660,085Harlan S. Robins · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Immuno and Epigenetics of Hematopoietic Cell Transplantation
$660,012Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Development of C57BL/6 ES cell technology for high thoughput use.
$659,999Klaus H. Kaestner · University Of Pennsylvania · U01 · FY2007 · DA
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
$659,913Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
New retroviral restriction factor
$659,848Tatyana V. Golovkina · University Of Chicago · R01 · FY2016 · AI
Occupational and Environmental Determinants of Cancer among Women and Minorities
$659,830Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Functional and translational studies of RUNX1 and CBFB in hematopoiesis
$659,796Paul Liu · National Human Genome Research Institute · ZIA · FY2014 · HG
Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma
$659,626Robert Taylor Ripley · Baylor College Of Medicine · R37 · FY2025 · CA
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
$659,613Scott Kopetz · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Role of Phase separation by fusion oncoproteins in oncogenesis
$659,374Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Interrogating the minor spliceosome to understand and treat leukemia
$659,229Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia
$659,161Austin L Brown · Baylor College Of Medicine · R01 · FY2023 · CA
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL
$659,113Peter D. Cole · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Neurostimulation in Adult Survivors of Childhood Leukemia
$659,031Tara M Brinkman · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models
$658,908Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Core C: High Dimensional Cellular and Spatial Analysis
$658,874Evan Newell · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Core C: High Dimensional Cellular and Spatial Analysis
$658,874Evan Newell · Fred Hutchinson Cancer Center · P01 · FY2024 · CA